As mentioned above, cases which acquire TET2 or DNMT3A mutations before the JAK2 mutation more often have an ET phenotype [35,88], and the two different types of CALR mutations are more balanced in ET vs. PMF [93]. The gene discussed is JAK2; the disease is essential thrombocythemia.